Good signs ...., page-489

Stockh##d in their morning newsletter today nominates Optiscan a leader in the Health and Biotech sector for June.
They show Actinogen Medical advancing by 138% for the month with Optiscan at a 124% increase not far behind. They comment on Optiscan:
"Optiscan soared in early June after introducing a groundbreaking medical imaging device called InVue, aimed at revolutionising surgery by providing surgeons with immediate access to digital pathology during operations.
"This technology allows surgeons to make instant decisions and adjustments, improving precision in surgeries.
"Traditionally, pathology testing has been done in separate labs and involves time-consuming processes with delayed results. InVue changes this by offering real-time pathology insights directly in the operating room.
"Developed in Melbourne in collaboration with Design + Industry, the device is designed for ease of use in clinical settings, particularly in cancer diagnosis and treatment,..
"InVue enables surgeons to view microscopic images and pathology details instantly, enhancing diagnostic accuracy and potentially reducing the need for multiple procedures and repeat surgeries".

MM